- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Ranibizumab, sold under the brand name Lucentis among others, is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab.
According to our latest study, the global Ranibizumab market size was valued at USD 3549.5 million in 2022 and is forecast to a readjusted size of USD 1768.3 million by 2029 with a CAGR of -9.5% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global core ranibizumab manufacturers include Roche and Novartis etc. The Top 2 companies hold a share about 98%. North America is the largest market, with a share about 51%, followed by Europe and Asia Pacific with the share about 28% and 20%.
This report is a detailed and comprehensive analysis for global Ranibizumab market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Ranibizumab market size and forecasts, in consumption value ($ Million), 2018-2029
Global Ranibizumab market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Ranibizumab market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Ranibizumab market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Ranibizumab
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Ranibizumab market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche and Novartis.. etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Ranibizumab market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Glass Vial
Prefilled Syringe
Market segment by Application
Wet AMD
Complications of Diabetes
RVO
Others
Market segment by players, this report covers
Roche
Novartis
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Ranibizumab product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Ranibizumab, with revenue, gross margin and global market share of Ranibizumab from 2018 to 2023.
Chapter 3, the Ranibizumab competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Ranibizumab market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Ranibizumab.
Chapter 13, to describe Ranibizumab research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Ranibizumab
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Ranibizumab by Type
1.3.1 Overview: Global Ranibizumab Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Ranibizumab Consumption Value Market Share by Type in 2022
1.3.3 Glass Vial
1.3.4 Prefilled Syringe
1.4 Global Ranibizumab Market by Application
1.4.1 Overview: Global Ranibizumab Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Wet AMD
1.4.3 Complications of Diabetes
1.4.4 RVO
1.4.5 Others
1.5 Global Ranibizumab Market Size & Forecast
1.6 Global Ranibizumab Market Size and Forecast by Region
1.6.1 Global Ranibizumab Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Ranibizumab Market Size by Region, (2018-2029)
1.6.3 North America Ranibizumab Market Size and Prospect (2018-2029)
1.6.4 Europe Ranibizumab Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Ranibizumab Market Size and Prospect (2018-2029)
1.6.6 South America Ranibizumab Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Ranibizumab Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Ranibizumab Product and Solutions
2.1.4 Roche Ranibizumab Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Ranibizumab Product and Solutions
2.2.4 Novartis Ranibizumab Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Novartis Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Ranibizumab Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Ranibizumab by Company Revenue
3.2.2 Top 3 Ranibizumab Players Market Share in 2022
3.2.3 Top 6 Ranibizumab Players Market Share in 2022
3.3 Ranibizumab Market: Overall Company Footprint Analysis
3.3.1 Ranibizumab Market: Region Footprint
3.3.2 Ranibizumab Market: Company Product Type Footprint
3.3.3 Ranibizumab Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Ranibizumab Consumption Value and Market Share by Type (2018-2023)
4.2 Global Ranibizumab Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Ranibizumab Consumption Value Market Share by Application (2018-2023)
5.2 Global Ranibizumab Market Forecast by Application (2024-2029)
6 North America
6.1 North America Ranibizumab Consumption Value by Type (2018-2029)
6.2 North America Ranibizumab Consumption Value by Application (2018-2029)
6.3 North America Ranibizumab Market Size by Country
6.3.1 North America Ranibizumab Consumption Value by Country (2018-2029)
6.3.2 United States Ranibizumab Market Size and Forecast (2018-2029)
6.3.3 Canada Ranibizumab Market Size and Forecast (2018-2029)
6.3.4 Mexico Ranibizumab Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Ranibizumab Consumption Value by Type (2018-2029)
7.2 Europe Ranibizumab Consumption Value by Application (2018-2029)
7.3 Europe Ranibizumab Market Size by Country
7.3.1 Europe Ranibizumab Consumption Value by Country (2018-2029)
7.3.2 Germany Ranibizumab Market Size and Forecast (2018-2029)
7.3.3 France Ranibizumab Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Ranibizumab Market Size and Forecast (2018-2029)
7.3.5 Russia Ranibizumab Market Size and Forecast (2018-2029)
7.3.6 Italy Ranibizumab Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Ranibizumab Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Ranibizumab Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Ranibizumab Market Size by Region
8.3.1 Asia-Pacific Ranibizumab Consumption Value by Region (2018-2029)
8.3.2 China Ranibizumab Market Size and Forecast (2018-2029)
8.3.3 Japan Ranibizumab Market Size and Forecast (2018-2029)
8.3.4 South Korea Ranibizumab Market Size and Forecast (2018-2029)
8.3.5 India Ranibizumab Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Ranibizumab Market Size and Forecast (2018-2029)
8.3.7 Australia Ranibizumab Market Size and Forecast (2018-2029)
9 South America
9.1 South America Ranibizumab Consumption Value by Type (2018-2029)
9.2 South America Ranibizumab Consumption Value by Application (2018-2029)
9.3 South America Ranibizumab Market Size by Country
9.3.1 South America Ranibizumab Consumption Value by Country (2018-2029)
9.3.2 Brazil Ranibizumab Market Size and Forecast (2018-2029)
9.3.3 Argentina Ranibizumab Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Ranibizumab Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Ranibizumab Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Ranibizumab Market Size by Country
10.3.1 Middle East & Africa Ranibizumab Consumption Value by Country (2018-2029)
10.3.2 Turkey Ranibizumab Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Ranibizumab Market Size and Forecast (2018-2029)
10.3.4 UAE Ranibizumab Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Ranibizumab Market Drivers
11.2 Ranibizumab Market Restraints
11.3 Ranibizumab Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Ranibizumab Industry Chain
12.2 Ranibizumab Upstream Analysis
12.3 Ranibizumab Midstream Analysis
12.4 Ranibizumab Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Ranibizumab Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Ranibizumab Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Ranibizumab Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Ranibizumab Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Roche Company Information, Head Office, and Major Competitors
Table 6. Roche Major Business
Table 7. Roche Ranibizumab Product and Solutions
Table 8. Roche Ranibizumab Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Roche Recent Developments and Future Plans
Table 10. Novartis Company Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Ranibizumab Product and Solutions
Table 13. Novartis Ranibizumab Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Novartis Recent Developments and Future Plans
Table 15. Global Ranibizumab Revenue (USD Million) by Players (2018-2023)
Table 16. Global Ranibizumab Revenue Share by Players (2018-2023)
Table 17. Breakdown of Ranibizumab by Company Type (Tier 1, Tier 2, and Tier 3)
Table 18. Market Position of Players in Ranibizumab, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 19. Head Office of Key Ranibizumab Players
Table 20. Ranibizumab Market: Company Product Type Footprint
Table 21. Ranibizumab Market: Company Product Application Footprint
Table 22. Ranibizumab New Market Entrants and Barriers to Market Entry
Table 23. Ranibizumab Mergers, Acquisition, Agreements, and Collaborations
Table 24. Global Ranibizumab Consumption Value (USD Million) by Type (2018-2023)
Table 25. Global Ranibizumab Consumption Value Share by Type (2018-2023)
Table 26. Global Ranibizumab Consumption Value Forecast by Type (2024-2029)
Table 27. Global Ranibizumab Consumption Value by Application (2018-2023)
Table 28. Global Ranibizumab Consumption Value Forecast by Application (2024-2029)
Table 29. North America Ranibizumab Consumption Value by Type (2018-2023) & (USD Million)
Table 30. North America Ranibizumab Consumption Value by Type (2024-2029) & (USD Million)
Table 31. North America Ranibizumab Consumption Value by Application (2018-2023) & (USD Million)
Table 32. North America Ranibizumab Consumption Value by Application (2024-2029) & (USD Million)
Table 33. North America Ranibizumab Consumption Value by Country (2018-2023) & (USD Million)
Table 34. North America Ranibizumab Consumption Value by Country (2024-2029) & (USD Million)
Table 35. Europe Ranibizumab Consumption Value by Type (2018-2023) & (USD Million)
Table 36. Europe Ranibizumab Consumption Value by Type (2024-2029) & (USD Million)
Table 37. Europe Ranibizumab Consumption Value by Application (2018-2023) & (USD Million)
Table 38. Europe Ranibizumab Consumption Value by Application (2024-2029) & (USD Million)
Table 39. Europe Ranibizumab Consumption Value by Country (2018-2023) & (USD Million)
Table 40. Europe Ranibizumab Consumption Value by Country (2024-2029) & (USD Million)
Table 41. Asia-Pacific Ranibizumab Consumption Value by Type (2018-2023) & (USD Million)
Table 42. Asia-Pacific Ranibizumab Consumption Value by Type (2024-2029) & (USD Million)
Table 43. Asia-Pacific Ranibizumab Consumption Value by Application (2018-2023) & (USD Million)
Table 44. Asia-Pacific Ranibizumab Consumption Value by Application (2024-2029) & (USD Million)
Table 45. Asia-Pacific Ranibizumab Consumption Value by Region (2018-2023) & (USD Million)
Table 46. Asia-Pacific Ranibizumab Consumption Value by Region (2024-2029) & (USD Million)
Table 47. South America Ranibizumab Consumption Value by Type (2018-2023) & (USD Million)
Table 48. South America Ranibizumab Consumption Value by Type (2024-2029) & (USD Million)
Table 49. South America Ranibizumab Consumption Value by Application (2018-2023) & (USD Million)
Table 50. South America Ranibizumab Consumption Value by Application (2024-2029) & (USD Million)
Table 51. South America Ranibizumab Consumption Value by Country (2018-2023) & (USD Million)
Table 52. South America Ranibizumab Consumption Value by Country (2024-2029) & (USD Million)
Table 53. Middle East & Africa Ranibizumab Consumption Value by Type (2018-2023) & (USD Million)
Table 54. Middle East & Africa Ranibizumab Consumption Value by Type (2024-2029) & (USD Million)
Table 55. Middle East & Africa Ranibizumab Consumption Value by Application (2018-2023) & (USD Million)
Table 56. Middle East & Africa Ranibizumab Consumption Value by Application (2024-2029) & (USD Million)
Table 57. Middle East & Africa Ranibizumab Consumption Value by Country (2018-2023) & (USD Million)
Table 58. Middle East & Africa Ranibizumab Consumption Value by Country (2024-2029) & (USD Million)
Table 59. Ranibizumab Raw Material
Table 60. Key Suppliers of Ranibizumab Raw Materials
List of Figures
Figure 1. Ranibizumab Picture
Figure 2. Global Ranibizumab Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Ranibizumab Consumption Value Market Share by Type in 2022
Figure 4. Glass Vial
Figure 5. Prefilled Syringe
Figure 6. Global Ranibizumab Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Ranibizumab Consumption Value Market Share by Application in 2022
Figure 8. Wet AMD Picture
Figure 9. Complications of Diabetes Picture
Figure 10. RVO Picture
Figure 11. Others Picture
Figure 12. Global Ranibizumab Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Ranibizumab Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Ranibizumab Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Ranibizumab Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Ranibizumab Consumption Value Market Share by Region in 2022
Figure 17. North America Ranibizumab Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Ranibizumab Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Ranibizumab Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Ranibizumab Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Ranibizumab Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Ranibizumab Revenue Share by Players in 2022
Figure 23. Ranibizumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Ranibizumab Market Share in 2022
Figure 25. Global Top 6 Players Ranibizumab Market Share in 2022
Figure 26. Global Ranibizumab Consumption Value Share by Type (2018-2023)
Figure 27. Global Ranibizumab Market Share Forecast by Type (2024-2029)
Figure 28. Global Ranibizumab Consumption Value Share by Application (2018-2023)
Figure 29. Global Ranibizumab Market Share Forecast by Application (2024-2029)
Figure 30. North America Ranibizumab Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Ranibizumab Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Ranibizumab Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Ranibizumab Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Ranibizumab Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Ranibizumab Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Ranibizumab Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Ranibizumab Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Ranibizumab Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Ranibizumab Consumption Value (2018-2029) & (USD Million)
Figure 40. France Ranibizumab Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Ranibizumab Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Ranibizumab Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Ranibizumab Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Ranibizumab Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Ranibizumab Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Ranibizumab Consumption Value Market Share by Region (2018-2029)
Figure 47. China Ranibizumab Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Ranibizumab Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Ranibizumab Consumption Value (2018-2029) & (USD Million)
Figure 50. India Ranibizumab Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Ranibizumab Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Ranibizumab Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Ranibizumab Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Ranibizumab Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Ranibizumab Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Ranibizumab Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Ranibizumab Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Ranibizumab Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Ranibizumab Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Ranibizumab Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Ranibizumab Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Ranibizumab Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Ranibizumab Consumption Value (2018-2029) & (USD Million)
Figure 64. Ranibizumab Market Drivers
Figure 65. Ranibizumab Market Restraints
Figure 66. Ranibizumab Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Ranibizumab in 2022
Figure 69. Manufacturing Process Analysis of Ranibizumab
Figure 70. Ranibizumab Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
